SCHEMBL26224146

SCHEMBL26224146

CCC[C@@H](NC(=O)OCCCCn1cnc2c(N)nc(N)cc21)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.37
▸ HTT P42858 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ LMNA P02545 3/20 0.36
▸ MAPT P10636 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ FAAH O00519 2/20 0.36
▸ PPARG P37231 5/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ TACR3 P29371 2/20 0.35
▸ TLR7 Q9NYK1 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.34
▸ TMIGD3 P0DMS9 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CTSK P43235 1/20 0.33
▸ MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19575724 0.86 PPARG (0.37) ALDH1A1HTTSMN1; SMN2LMNAMAPT
SCHEMBL26212223 0.85 TMIGD3 (0.41) ALDH1A1HTTSMN1; SMN2LMNAFAAH
SCHEMBL19575371 0.85 TMIGD3 (0.41) ALDH1A1HTTSMN1; SMN2LMNAFAAH
SCHEMBL19575392 0.85 ALDH1A1 (0.39) ALDH1A1HTTSMN1; SMN2LMNAMAPT
SCHEMBL19575642 0.84 SERPINA3 (0.47) ALDH1A1HTTSMN1; SMN2LMNAFAAH
SCHEMBL26212539 0.84 HDAC1 (0.42) TMIGD3ADORA2AADORA1
SCHEMBL19575639 0.84 HDAC1 (0.42) TMIGD3ADORA2AADORA1
SCHEMBL26212252 0.84 SERPINA3 (0.47) ALDH1A1HTTSMN1; SMN2LMNAFAAH
SCHEMBL26212177 0.83 ADORA2A (0.49) ALDH1A1SMN1; SMN2LMNAADORA2AADORA1
SCHEMBL19574920 0.83 ADORA2A (0.49) ALDH1A1SMN1; SMN2LMNAADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452477-B1 ADENINE DERIVATIVES AS PROTEIN KINASE INHIBITORS B C I PHARMA (BE) 2023-09-13 — — EP disclosed
Send feedback